Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hasler

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Springer Seminars in Immunopathology|June 2, 2006
Biological immunomodulatorsPaul Hasler
Springer Seminars in Immunopathology|June 2, 2006
Biological therapies directed against cells in autoimmune diseasePaul Hasler
Expert Opinion on Therapeutic Targets|January 31, 2003
Highlights of frontiers in autoimmunity: fundamental aspects and clinical perspectivesPaul Hasler, Moncef Zouali
Cellular Immunology|June 7, 2005
Immune receptor signaling, aging, and autoimmunityPaul Hasler, Moncef Zouali
Praxis|November 5, 2010
[[Reactive arthritis]Christina Ryser, Paul Hasler
Expert Opinion on Therapeutic Targets|November 16, 2006
B lymphocytes as therapeutic targets in systemic lupus erythematosusPaul Hasler, Moncef Zouali
Seminars in Immunopathology|June 12, 2013
Special issue on neutrophilsPaul Hasler, Sinuhe Hahn
Seminars in Immunopathology|June 23, 2017
Rheumatoid arthritis: from basic findings and clinical manifestations to future therapiesPaul Hasler, Cem Gabay
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Safety and efficacy of biologics directed against TNF-alpha and CD20 in the therapy of vasculitis and systemic lupus erythematosus]Ulrich A Walker, Paul Hasler
Journal of Clinical Medicine|August 14, 2020
Rheumatoid Arthritis from Pathogenesis to Therapeutic StrategiesRuediger B Mueller, Paul Hasler
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Springer Seminars in Immunopathology|June 2, 2006
Biological immunomodulatorsPaul Hasler
Springer Seminars in Immunopathology|June 2, 2006
Biological therapies directed against cells in autoimmune diseasePaul Hasler
Expert Opinion on Therapeutic Targets|January 31, 2003
Highlights of frontiers in autoimmunity: fundamental aspects and clinical perspectivesPaul Hasler, Moncef Zouali
Cellular Immunology|June 7, 2005
Immune receptor signaling, aging, and autoimmunityPaul Hasler, Moncef Zouali
Praxis|November 5, 2010
[[Reactive arthritis]Christina Ryser, Paul Hasler
Expert Opinion on Therapeutic Targets|November 16, 2006
B lymphocytes as therapeutic targets in systemic lupus erythematosusPaul Hasler, Moncef Zouali
Seminars in Immunopathology|June 12, 2013
Special issue on neutrophilsPaul Hasler, Sinuhe Hahn
Seminars in Immunopathology|June 23, 2017
Rheumatoid arthritis: from basic findings and clinical manifestations to future therapiesPaul Hasler, Cem Gabay
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Safety and efficacy of biologics directed against TNF-alpha and CD20 in the therapy of vasculitis and systemic lupus erythematosus]Ulrich A Walker, Paul Hasler
Journal of Clinical Medicine|August 14, 2020
Rheumatoid Arthritis from Pathogenesis to Therapeutic StrategiesRuediger B Mueller, Paul Hasler
Pageof 7